Patent: 10,058,600
✉ Email this page to a colleague
Summary for Patent: 10,058,600
| Title: | Detoxified Escherichia coli immunogens |
| Abstract: | Detoxified variants of the pathogenic E. coli `AcfD precursor` (orf3526) have been identified that raise a substantially similar immune response in a subject as the native AcfD (orB526) protein. The detoxified variants may be further modified to have increased solubility as compared to the native AcfD (orf3526) protein. |
| Inventor(s): | Serino; Laura (Siena, IT), Fontana; Maria Rita (Siena, IT), Gomes Moriel; Danilo (Siena, IT) |
| Assignee: | GLAXOSMITHKLINE BIOLOGICALS SA (Rixensart, BE) |
| Application Number: | 14/525,033 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,058,600
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Emergent Biodefense Operations Lansing Llc | BIOTHRAX | anthrax vaccine adsorbed | Injection | 103821 | 11/12/1998 | ⤷ Try a Trial | 2029-07-16 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
